{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:33:06Z","timestamp":1778293986711,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11046-025-01004-x","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:34:35Z","timestamp":1758893675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mortality and Treatment Outcomes in Pediatric Malignancy Patients with Invasive Cutaneous Fungal Infections: Evaluating the Impact of Combination Therapy and Surgical Debridement, Experience from Referral Oncology Teaching Hospital"],"prefix":"10.1007","volume":"190","author":[{"given":"Seyed Reza","family":"Abdipour Mehrian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadi","family":"Mottaghipisheh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadis","family":"Jafarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Homayounifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser","family":"Pourasghar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fateme","family":"Noushadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armina","family":"Farkarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Meftah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1406-1114","authenticated-orcid":false,"given":"Sadra","family":"Valiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-2853","authenticated-orcid":false,"given":"Ali","family":"Amanati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"1004_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-3-319-04220-6_10","volume":"161","author":"M Gandhi","year":"2014","unstructured":"Gandhi M, Brieva JC, Lacouture ME. Dermatologic infections in cancer patients. Cancer Treat Res. 2014;161:299\u2013317.","journal-title":"Cancer Treat Res"},{"issue":"3","key":"1004_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/jpids\/pix030","volume":"7","author":"BT Fisher","year":"2018","unstructured":"Fisher BT, Robinson PD, Lehrnbecher T, Steinbach WJ, Zaoutis TE, Phillips B, et al. Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review. J Pediatr Infect Dis Soc. 2018;7(3):191\u20138.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"9","key":"1004_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/myc.12928","volume":"62","author":"AJ Maddy","year":"2019","unstructured":"Maddy AJ, Sanchez N, Shukla BS, Maderal AD. Dermatological manifestations of fungal infection in patients with febrile neutropaenia: a review of the literature. Mycoses. 2019;62(9):826\u201334.","journal-title":"Mycoses"},{"issue":"4","key":"1004_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1542\/peds.2006-2931","volume":"119","author":"CC Blyth","year":"2007","unstructured":"Blyth CC, Palasanthiran P, O\u2019Brien TA. Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics. 2007;119(4):772\u201384.","journal-title":"Pediatrics"},{"issue":"9398","key":"1004_CR5","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","volume":"362","author":"MS Lionakis","year":"2003","unstructured":"Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003;362(9398):1828\u201338.","journal-title":"Lancet"},{"key":"1004_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/BF02113581","volume":"25","author":"P Verweij","year":"1997","unstructured":"Verweij P, Meis J, Dompeling E, Donnelly J, Schattenberg A. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection. 1997;25:86\u20139.","journal-title":"Infection"},{"issue":"4","key":"1004_CR7","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1542\/peds.2005-1161","volume":"117","author":"TE Zaoutis","year":"2006","unstructured":"Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics. 2006;117(4):e711\u20136.","journal-title":"Pediatrics"},{"key":"1004_CR8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.6.1430.bloodjournal8061430","author":"R Pettengell","year":"1992","unstructured":"Pettengell R, Gurney H, Radford JA, Deakin DP, James R, Wilkinson PM, et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin\u2019s lymphoma: a randomized controlled trial. Blood. 1992. https:\/\/doi.org\/10.1182\/blood.V80.6.1430.bloodjournal8061430.","journal-title":"Blood"},{"issue":"6229","key":"1004_CR9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1126\/science.aaa6097","volume":"347","author":"DW Denning","year":"2015","unstructured":"Denning DW, Bromley MJ. How to bolster the antifungal pipeline. Science. 2015;347(6229):1414\u20136.","journal-title":"Science"},{"issue":"7","key":"1004_CR10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2007.140087","volume":"20","author":"D Bitar","year":"2014","unstructured":"Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, et al. Population-based analysis of invasive fungal infections, France, 2001\u20132010. Emerg Infect Dis. 2014;20(7):1149.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"1004_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31031","volume":"71","author":"N Jain","year":"2024","unstructured":"Jain N, Ryan AL, Haeusler GM, McMullan BJ, Moore AS, Bartlett AW, et al. Invasive fungal disease in children with solid tumors: an Australian multicenter 10-year review. Pediatr Blood Cancer. 2024;71(7):e31031.","journal-title":"Pediatr Blood Cancer"},{"key":"1004_CR12","first-page":"24","volume":"4","author":"DN Joshi","year":"2022","unstructured":"Joshi DN, Shenoy B. T2 candida panel: a game changer in diagnosis of fungal infections. Pediatr Infect Dis. 2022;4:24\u20135.","journal-title":"Pediatr Infect Dis"},{"issue":"1","key":"1004_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-023-00926-2","volume":"30","author":"W Fang","year":"2023","unstructured":"Fang W, Wu J, Cheng M, Zhu X, Du M, Chen C, et al. Diagnosis of invasive fungal infections: challenges and recent developments. J Biomed Sci. 2023;30(1):42.","journal-title":"J Biomed Sci"},{"issue":"1","key":"1004_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nri1255","volume":"4","author":"L Romani","year":"2004","unstructured":"Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4(1):11\u201324.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"1004_CR15","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","volume":"17","author":"O Lortholary","year":"2011","unstructured":"Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y, et al. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007). Clin Microbiol Infect. 2011;17(12):1882\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1004_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/myc.12628","volume":"60","author":"OA Cornely","year":"2017","unstructured":"Cornely OA, Lass-Fl\u00f6rl C, Lagrou K, Arsic-Arsenijevic V, Hoenigl M. Improving outcome of fungal diseases\u2013guiding experts and patients towards excellence. Mycoses. 2017;60(7):420\u20135.","journal-title":"Mycoses"},{"issue":"3","key":"1004_CR17","first-page":"155","volume":"35","author":"A St John","year":"2014","unstructured":"St John A, Price CP. Existing and emerging technologies for point-of-care testing. The Clinical Biochemist Reviews. 2014;35(3):155.","journal-title":"The Clinical Biochemist Reviews"},{"issue":"3","key":"1004_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/metabo10030106","volume":"10","author":"J Hou\u0161\u0165","year":"2020","unstructured":"Hou\u0161\u0165 J, Sp\u00ed\u017eek J, Havl\u00ed\u010dek V. Antifungal drugs. Metabolites. 2020;10(3):106.","journal-title":"Metabolites"},{"key":"1004_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40506-014-0016-2","volume":"6","author":"AA Panackal","year":"2014","unstructured":"Panackal AA, Bennett JE, Williamson PR. Treatment options in invasive aspergillosis. Curr Treat Options Infect Dis. 2014;6:309\u201325.","journal-title":"Curr Treat Options Infect Dis"},{"issue":"10","key":"1004_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186422","volume":"12","author":"K-S Sun","year":"2017","unstructured":"Sun K-S, Tsai C-F, Chen SC-C, Huang W-C. Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: an 11-year follow-up report from Taiwan. PLoS ONE. 2017;12(10):e0186422.","journal-title":"PLoS ONE"},{"issue":"4","key":"1004_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50.","journal-title":"Clin Infect Dis"},{"key":"1004_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12281-013-0172-8","volume":"8","author":"DJ Nieves","year":"2014","unstructured":"Nieves DJ, Arrieta AC. Recent studies on invasive fungal diseases in children and adolescents: an update. Curr Fungal Infect Rep. 2014;8:56\u201366.","journal-title":"Curr Fungal Infect Rep"},{"issue":"6","key":"1004_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"key":"1004_CR24","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, De Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol. 2016;27:v111\u20138.","journal-title":"Ann Oncol"},{"issue":"9","key":"1004_CR25","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1200\/JCO.22.02224","volume":"41","author":"T Lehrnbecher","year":"2023","unstructured":"Lehrnbecher T, Robinson PD, Ammann RA, Fisher B, Patel P, Phillips R, et al. Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update. J Clin Oncol. 2023;41(9):1774\u201385.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1004_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1128\/CMR.18.1.163-194.2005","volume":"18","author":"PK Mukherjee","year":"2005","unstructured":"Mukherjee PK, Sheehan DJ, Hitchcock CA, Ghannoum MA. Combination treatment of invasive fungal infections. Clin Microbiol Rev. 2005;18(1):163\u201394.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"1004_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","volume":"8","author":"M Spitzer","year":"2017","unstructured":"Spitzer M, Robbins N, Wright GD. Combinatorial strategies for combating invasive fungal infections. Virulence. 2017;8(2):169\u201385.","journal-title":"Virulence"},{"issue":"1","key":"1004_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12281-020-00369-4","volume":"14","author":"SJ Livengood","year":"2020","unstructured":"Livengood SJ, Drew RH, Perfect JR. Combination therapy for invasive fungal infections. Curr Fungal Infect Rep. 2020;14(1):40\u20139.","journal-title":"Curr Fungal Infect Rep"},{"issue":"1","key":"1004_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","volume":"93","author":"S Mousset","year":"2014","unstructured":"Mousset S, Buchheidt D, Heinz W, Ruhnke M, Cornely OA, Egerer G, et al. Treatment of invasive fungal infections in cancer patients\u2014updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2014;93(1):13\u201332.","journal-title":"Ann Hematol"},{"key":"1004_CR30","first-page":"204993612312249","volume":"11","author":"C-A Boutin","year":"2024","unstructured":"Boutin C-A, Luong M-L. Update on therapeutic approaches for invasive fungal infections in adults. Ther Adv Infect Dis. 2024;11:20499361231224980.","journal-title":"Ther Adv Infect Dis"},{"key":"1004_CR31","unstructured":"Research Ethics Committees Certificate. The prevalence of invasive Aspergillosis and Mucormycosis skin and soft tissue infections of in children with malignancy in Amir Oncology Hospital during 2015\u20132022, Shiraz, Iran 2022 [Available from: ethics.research.ac.ir\/ProposalCertificateEn.php?id=301274&Print=true&NoPrintHeader=true&NoPrintFooter=true&NoPrintPageBorder=true&LetterPrint=true."},{"key":"1004_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-2005-1","volume":"16","author":"ZD Pana","year":"2016","unstructured":"Pana ZD, Seidel D, Skiada A, Groll AH, Petrikkos G, Cornely OA, et al. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. BMC Infect Dis. 2016;16:1\u20139.","journal-title":"BMC Infect Dis"},{"key":"1004_CR33","doi-asserted-by":"crossref","unstructured":"Webb BJ, Ferraro JP, Rea S, Kaufusi S, Goodman BE, Spalding J, editors. Epidemiology and clinical features of invasive fungal infection in a US health care network. Open forum infectious diseases; 2018: Oxford University Press US.","DOI":"10.1093\/ofid\/ofy187"},{"issue":"11","key":"1004_CR34","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/myc.12915","volume":"62","author":"Y Madney","year":"2019","unstructured":"Madney Y, Khedr R, Ahmed N, El-Mahallawy H, Youssef A, Taha H, et al. Overview and outcome of mucormycosis among children with cancer: report from the Children\u2019s Cancer Hospital Egypt. Mycoses. 2019;62(11):984\u20139.","journal-title":"Mycoses"},{"issue":"4","key":"1004_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27564","volume":"66","author":"AW Bartlett","year":"2019","unstructured":"Bartlett AW, Cann MP, Yeoh DK, Bernard A, Ryan AL, Blyth CC, et al. Epidemiology of invasive fungal infections in immunocompromised children; an Australian national 10-year review. Pediatr Blood Cancer. 2019;66(4):e27564.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1004_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac014","volume":"60","author":"F Al Dhaheri","year":"2022","unstructured":"Al Dhaheri F, Lee RA, Sharma TS, Nakamura MM, Marty FM. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: a 12-year single-center experience. Med Mycol. 2022;60(4):myac014.","journal-title":"Med Mycol"},{"issue":"9","key":"1004_CR37","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1097\/INF.0000000000003608","volume":"41","author":"YG Loeffen","year":"2022","unstructured":"Loeffen YG, Scharloo F, Goemans BF, Heitink-Polle KM, Lindemans CA, Van Der Bruggen T, et al. Mucormycosis in children with hematologic malignancies: a case series and review of the literature. Pediatr Infect Dis J. 2022;41(9):e369\u201376.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"1004_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/jof7030165","volume":"7","author":"S Elitzur","year":"2021","unstructured":"Elitzur S, Fischer S, Arad-Cohen N, Barg A, Ben-Harosh M, Danino D, et al. Disseminated mucormycosis in immunocompromised children: are new antifungal agents making a difference? A multicenter retrospective study. J Fungi. 2021;7(3):165.","journal-title":"J Fungi"},{"issue":"3","key":"1004_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/mmy\/myu086","volume":"53","author":"K Bala","year":"2015","unstructured":"Bala K, Chander J, Handa U, Punia RS, Attri AK. A prospective study of mucormycosis in north India: experience from a tertiary care hospital. Med Mycol. 2015;53(3):248\u201357.","journal-title":"Med Mycol"},{"key":"1004_CR40","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s10096-011-1425-5","volume":"31","author":"F Jacobs","year":"2012","unstructured":"Jacobs F, Selleslag D, Aoun M, Sonet A, Gadisseur A. An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole. Eur J Clin Microbiol Infect Dis. 2012;31:1173\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"1004_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jaad.2009.02.052","volume":"61","author":"D Marcoux","year":"2009","unstructured":"Marcoux D, Jafarian F, Joncas V, Buteau C, Kokta V, Moghrabi A. Deep cutaneous fungal infections in immunocompromised children. J Am Acad Dermatol. 2009;61(5):857\u201364.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1004_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/0255-0857.62498","volume":"28","author":"A Kindo","year":"2010","unstructured":"Kindo A, Rana N, Rekha A, Kalyani J. Fungal infections in the soft tissue: a study from a tertiary care center. Indian J Med Microbiol. 2010;28(2):164\u20136.","journal-title":"Indian J Med Microbiol"},{"key":"1004_CR43","doi-asserted-by":"publisher","DOI":"10.3410\/M3-14","volume":"3","author":"C-Y Low","year":"2011","unstructured":"Low C-Y, Rotstein C. Emerging fungal infections in immunocompromised patients. F1000 Med Rep. 2011;3:14.","journal-title":"F1000 Med Rep"},{"issue":"6","key":"1004_CR44","first-page":"634","volume":"151","author":"A Borghi","year":"2015","unstructured":"Borghi A, Corazza M, Minghetti S, Biolo G, Maritati M, Virgili A. Mycological visits requested in a tertiary referral center: what can be hiding behind a suspected skin mycosis? Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia. 2015;151(6):634\u201341.","journal-title":"Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia"},{"key":"1004_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","volume":"97","author":"SC Mellinghoff","year":"2018","unstructured":"Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, et al. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Ann Hematol. 2018;97:197\u2013207.","journal-title":"Ann Hematol"},{"key":"1004_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s15010-013-0525-9","volume":"42","author":"L Nesher","year":"2014","unstructured":"Nesher L, Rolston KV. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection. 2014;42:5\u201313.","journal-title":"Infection"},{"issue":"35","key":"1004_CR47","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","volume":"30","author":"T Lehrnbecher","year":"2012","unstructured":"Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2012;30(35):4427\u201338.","journal-title":"J Clin Oncol"},{"key":"1004_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11046-015-9953-7","volume":"181","author":"O Faure-Cognet","year":"2016","unstructured":"Faure-Cognet O, Fricker-Hidalgo H, Pelloux H, Leccia M. Superficial fungal infections in a French teaching hospital in Grenoble area: retrospective study on 5470 samples from 2001 to 2011. Mycopathologia. 2016;181:59\u201366.","journal-title":"Mycopathologia"},{"issue":"1","key":"1004_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12281-018-0306-0","volume":"12","author":"S Antinori","year":"2018","unstructured":"Antinori S, Corbellino M, Parravicini C. Challenges in the diagnosis of invasive fungal infections in immunocompromised hosts. Curr Fungal Infect Rep. 2018;12(1):12\u201322.","journal-title":"Curr Fungal Infect Rep"},{"issue":"2","key":"1004_CR50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/jof7020127","volume":"7","author":"Z Freeman Weiss","year":"2021","unstructured":"Freeman Weiss Z, Leon A, Koo S. The evolving landscape of fungal diagnostics, current and emerging microbiological approaches. Journal of Fungi. 2021;7(2):127.","journal-title":"Journal of Fungi"},{"issue":"3","key":"1004_CR51","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4103\/ijpm.ijpm_663_21","volume":"66","author":"SN Baxi","year":"2023","unstructured":"Baxi SN, Gohil MR, Navadiya AJ, Bapodra MK, Patel HR. Comparative evaluation of histopathological analysis, KOH wet mount and fungal culture to diagnose fungal infections in post-COVID patients. Indian J Pathol Microbiol. 2023;66(3):540\u20134.","journal-title":"Indian J Pathol Microbiol"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-01004-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-025-01004-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-01004-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T07:02:17Z","timestamp":1764140537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-025-01004-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1007\/s11046-025-01004-x","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted following the Helsinki guidelines, national norms, and regulations for medical research. This study was approved by the Research Ethics Committee of the School of Medicine at Shiraz University of Medical Sciences (approval ID: IR.SUMS.AH.REC.1401.439) [\n                      \n                      ]. All of the precipitants or their parents were informed about this study, and next-of-kin of all the patients gave written informed consent for their child\u2019s participation and anonymized use of their clinical data in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial Number"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"92"}}